Protect Yourself and Loved Ones with the New RSV Vaccines
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
University of California San Francisco
Give to UCSFThe FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
UCSF researchers are working across disease specialties. Diabetes researchers are looking at how oncologists use CAR T-cell therapy to reprogram a person’s immune system to attack cancer cells, for example. They hope to similarly reprogram the immune system to fight diabetes.
A brain implant and digital avatar allow a paralyzed stroke survivor to speak with for first time in 18 years with the help of artificial intelligence.
A newly identified platelet factor 4 (PF4) was found to help rejuvenate the old brain and boost the young brain, potentially opening the door to new therapies that aim to restore brain function
A new digital headset designed to measure alterations in brain function could change decisions about how quickly an athlete is ready to return to play after a concussion.
Long COVID symptoms can persist for a year after initial infection, or re-emerge months later after disappearing.
An experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
A common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home.
A rare burst of visual creativity is seen occasionally in patients with frontotemporal dementia. A UCSF-led study offers new insights into how this talent develops as key areas of the brain degenerate.
A large, collaborative study on multiple sclerosis (MS) severity found that a single gene variant is predictive of much faster neurodegeneration in MS patients.
UCSF infectious disease specialist Michael Peluso, MD, who co-leads one of the world’s oldest studies of long COVID, discusses the condition’s mysteries.
The advent of cheap, easy-to-use blood tests for Alzheimer’s disease has the potential to revolutionize diagnosis and treatment. But they also raise difficult questions that the field is only beginning to consider.
A new treatment approach draws on research into the unique teenage brain.
Two UCSF scientists – James Gardner, MD, PhD, and Rebeca de Pavia Fróes Rocha, PhD – have received Pew awards for their work in immunology as part of a program that supports promising early-career investigators.